サマリー

湿疹治療薬の世界市場 2022-2026 年
Technavioは湿疹治療薬市場を監視しており、2022-2026年の間に43億6000万ドルの成長が見込まれ、予測期間中にCAGR9.6％で加速しています。当レポートでは、湿疹治療薬市場について、全体的な分析、市場規模と予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを提供しています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境について最新の分析を提供しています。市場は強力なパイプラインのランドスケープによって牽引されています。
湿疹治療薬市場の分析には、適応症セグメントと地理的展望が含まれます。
Technavioの湿疹治療薬市場は、以下のように区分されています。
適応症別
- アトピー性皮膚炎
- 接触性皮膚炎
- その他
地域別状況
- 北アメリカ
- 欧州
- アジア
- その他の地域（ROW）
本調査では、今後数年間における湿疹治療薬市場の成長を促進する主要な理由の一つとして、ビジネス戦略を挙げています。また、地政学的な不確実性と医療費の増加は、市場の大規模な需要につながるでしょう。
Technavio社は、複数の情報源からのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。湿疹治療薬市場に関する当レポートは、以下の分野を対象としています。
- 湿疹治療薬市場のサイジング
- 湿疹治療薬市場の予測
- 湿疹治療薬市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って、本レポートでは、AbbVie Inc.を含む湿疹治療薬市場の主要ベンダー数社の詳細な分析を提供します。Alliance Pharma Plc、Amneal Pharmaceuticals Inc、AstraZeneca Plc、Bausch Health Co Inc、Bayer AG、Cadila Pharmaceuticals Ltd、Eli Lilly and Co、Glenmark Pharmaceuticals Ltd、Incyte Corp、LEO Pharma AS、Lupin Ltd.、Mayo Foundation for Medical Education and Research、Merck and Co.Inc.、Novartis AG、Pfizer Inc.、Regeneron Pharmaceuticals Inc.、Sanofi SA、Teva Pharmaceutical Industries Ltd.、Viatris Inc.の7社が含まれています。また、湿疹治療薬市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略的に活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/eczema-therapeutics-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Indication
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Indication
o 5.1 Market segments
o Exhibit 24: Chart on Indication - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Indication - Market share 2021-2026 (%)
o 5.2 Comparison by Indication
o Exhibit 26: Chart on Comparison by Indication
o Exhibit 27: Data Table on Comparison by Indication
o 5.3 Atopic dermatitis - Market size and forecast 2021-2026
o Exhibit 28: Chart on Atopic dermatitis - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Atopic dermatitis - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Atopic dermatitis - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Atopic dermatitis - Year-over-year growth 2021-2026 (%)
o 5.4 Contact dermatitis - Market size and forecast 2021-2026
o Exhibit 32: Chart on Contact dermatitis - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Contact dermatitis - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Contact dermatitis - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Contact dermatitis - Year-over-year growth 2021-2026 (%)
o 5.5 Other indication - Market size and forecast 2021-2026
o Exhibit 36: Chart on Other indication - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Other indication - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Other indication - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Other indication - Year-over-year growth 2021-2026 (%)
o 5.6 Market opportunity by Indication
o Exhibit 40: Market opportunity by Indication ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 44: Chart on Geographic comparison
o Exhibit 45: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 UK - Market size and forecast 2021-2026
o Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.10 France - Market size and forecast 2021-2026
o Exhibit 74: Chart on France - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on France - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on France - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on France - Year-over-year growth 2021-2026 (%)
o 7.11 Canada - Market size and forecast 2021-2026
o Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 82: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 83: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 85: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 86: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 87: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 88: Matrix on vendor position and classification
o 10.3 AbbVie Inc.
o Exhibit 89: AbbVie Inc. - Overview
o Exhibit 90: AbbVie Inc. - Product / Service
o Exhibit 91: AbbVie Inc. - Key offerings
o 10.4 Alliance Pharma Plc
o Exhibit 92: Alliance Pharma Plc - Overview
o Exhibit 93: Alliance Pharma Plc - Business segments
o Exhibit 94: Alliance Pharma Plc - Key offerings
o Exhibit 95: Alliance Pharma Plc - Segment focus
o 10.5 Amneal Pharmaceuticals Inc.
o Exhibit 96: Amneal Pharmaceuticals Inc. - Overview
o Exhibit 97: Amneal Pharmaceuticals Inc. - Business segments
o Exhibit 98: Amneal Pharmaceuticals Inc. - Key news
o Exhibit 99: Amneal Pharmaceuticals Inc. - Key offerings
o Exhibit 100: Amneal Pharmaceuticals Inc. - Segment focus
o 10.6 AstraZeneca Plc
o Exhibit 101: AstraZeneca Plc - Overview
o Exhibit 102: AstraZeneca Plc - Product / Service
o Exhibit 103: AstraZeneca Plc - Key news
o Exhibit 104: AstraZeneca Plc - Key offerings
o 10.7 Bausch Health Co Inc
o Exhibit 105: Bausch Health Co Inc - Overview
o Exhibit 106: Bausch Health Co Inc - Business segments
o Exhibit 107: Bausch Health Co Inc - Key news
o Exhibit 108: Bausch Health Co Inc - Key offerings
o Exhibit 109: Bausch Health Co Inc - Segment focus
o 10.8 Bayer AG
o Exhibit 110: Bayer AG - Overview
o Exhibit 111: Bayer AG - Business segments
o Exhibit 112: Bayer AG - Key offerings
o Exhibit 113: Bayer AG - Segment focus
o 10.9 Eli Lilly and Co.
o Exhibit 114: Eli Lilly and Co. - Overview
o Exhibit 115: Eli Lilly and Co. - Product / Service
o Exhibit 116: Eli Lilly and Co. - Key offerings
o 10.10 LEO Pharma AS
o Exhibit 117: LEO Pharma AS - Overview
o Exhibit 118: LEO Pharma AS - Business segments
o Exhibit 119: LEO Pharma AS - Key offerings
o Exhibit 120: LEO Pharma AS - Segment focus
o 10.11 Pfizer Inc.
o Exhibit 121: Pfizer Inc. - Overview
o Exhibit 122: Pfizer Inc. - Product / Service
o Exhibit 123: Pfizer Inc. - Key news
o Exhibit 124: Pfizer Inc. - Key offerings
o 10.12 Sanofi SA
o Exhibit 125: Sanofi SA - Overview
o Exhibit 126: Sanofi SA - Business segments
o Exhibit 127: Sanofi SA - Key news
o Exhibit 128: Sanofi SA - Key offerings
o Exhibit 129: Sanofi SA - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 130: Inclusions checklist
o Exhibit 131: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 132: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 133: Research methodology
o Exhibit 134: Validation techniques employed for market sizing
o Exhibit 135: Information sources
o 11.5 List of abbreviations
o Exhibit 136: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Indication
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Indication - Market share 2021-2026 (%)
Exhibits25: Data Table on Indication - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Indication
Exhibits27: Data Table on Comparison by Indication
Exhibits28: Chart on Atopic dermatitis - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Atopic dermatitis - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Atopic dermatitis - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Atopic dermatitis - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Contact dermatitis - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Contact dermatitis - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Contact dermatitis - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Contact dermatitis - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Other indication - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Other indication - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Other indication - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Other indication - Year-over-year growth 2021-2026 (%)
Exhibits40: Market opportunity by Indication ($ million)
Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits44: Chart on Geographic comparison
Exhibits45: Data Table on Geographic comparison
Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: AbbVie Inc. - Overview
Exhibits90: AbbVie Inc. - Product / Service
Exhibits91: AbbVie Inc. - Key offerings
Exhibits92: Alliance Pharma Plc - Overview
Exhibits93: Alliance Pharma Plc - Business segments
Exhibits94: Alliance Pharma Plc - Key offerings
Exhibits95: Alliance Pharma Plc - Segment focus
Exhibits96: Amneal Pharmaceuticals Inc. - Overview
Exhibits97: Amneal Pharmaceuticals Inc. - Business segments
Exhibits98: Amneal Pharmaceuticals Inc. - Key news
Exhibits99: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits100: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits101: AstraZeneca Plc - Overview
Exhibits102: AstraZeneca Plc - Product / Service
Exhibits103: AstraZeneca Plc - Key news
Exhibits104: AstraZeneca Plc - Key offerings
Exhibits105: Bausch Health Co Inc - Overview
Exhibits106: Bausch Health Co Inc - Business segments
Exhibits107: Bausch Health Co Inc - Key news
Exhibits108: Bausch Health Co Inc - Key offerings
Exhibits109: Bausch Health Co Inc - Segment focus
Exhibits110: Bayer AG - Overview
Exhibits111: Bayer AG - Business segments
Exhibits112: Bayer AG - Key offerings
Exhibits113: Bayer AG - Segment focus
Exhibits114: Eli Lilly and Co. - Overview
Exhibits115: Eli Lilly and Co. - Product / Service
Exhibits116: Eli Lilly and Co. - Key offerings
Exhibits117: LEO Pharma AS - Overview
Exhibits118: LEO Pharma AS - Business segments
Exhibits119: LEO Pharma AS - Key offerings
Exhibits120: LEO Pharma AS - Segment focus
Exhibits121: Pfizer Inc. - Overview
Exhibits122: Pfizer Inc. - Product / Service
Exhibits123: Pfizer Inc. - Key news
Exhibits124: Pfizer Inc. - Key offerings
Exhibits125: Sanofi SA - Overview
Exhibits126: Sanofi SA - Business segments
Exhibits127: Sanofi SA - Key news
Exhibits128: Sanofi SA - Key offerings
Exhibits129: Sanofi SA - Segment focus
Exhibits130: Inclusions checklist
Exhibits131: Exclusions checklist
Exhibits132: Currency conversion rates for US$
Exhibits133: Research methodology
Exhibits134: Validation techniques employed for market sizing
Exhibits135: Information sources
Exhibits136: List of abbreviations